European life sciences venture capital firm HealthCap appointed Dr. Mårten Steen as co-managing partner, taking a seat alongside Founding Partner Björn Odlander.
Mårten became a partner at the Stockholm, Sweden-based HealthCap in 2010 and has played key roles in many of the firm´s most successful investments, including Wilson Therapeutics, a developer of treatments for ultra-rare orphan diseases that was sold in 2020 for about $800 million.
HealthCap also announced a new hire and several other promotions.
- Kristina Ekberg joined HealthCap as partner and . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly$30A pay-as-you-go plan to get you startedJoin Now→ Instantly unlock all new and archived articles→ Daily, weekly and monthly e-mail newsletters→ Access to the weekly AW Deal Watch by AW ResearchAnnual$300Required for access to AW ResearchGet more for less - 20% discount over monthlyJoin Now→ Everything in Monthly PLUS:→ Access to articles and data from AW Research→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators